Cymat Technologies Stock Market Value

CYMHF Stock  USD 0.14  0.02  12.50%   
Cymat Technologies' market value is the price at which a share of Cymat Technologies trades on a public exchange. It measures the collective expectations of Cymat Technologies investors about its performance. Cymat Technologies is trading at 0.14 as of the 19th of July 2025. This is a 12.5 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.14.
With this module, you can estimate the performance of a buy and hold strategy of Cymat Technologies and determine expected loss or profit from investing in Cymat Technologies over a given investment horizon. Check out Cymat Technologies Correlation, Cymat Technologies Volatility and Cymat Technologies Alpha and Beta module to complement your research on Cymat Technologies.
Symbol

Please note, there is a significant difference between Cymat Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cymat Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cymat Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Cymat Technologies 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cymat Technologies' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cymat Technologies.
0.00
04/20/2025
No Change 0.00  0.0 
In 3 months and 1 day
07/19/2025
0.00
If you would invest  0.00  in Cymat Technologies on April 20, 2025 and sell it all today you would earn a total of 0.00 from holding Cymat Technologies or generate 0.0% return on investment in Cymat Technologies over 90 days. Cymat Technologies is related to or competes with Maanshan Iron, Ternium SA, Coca Cola, Diageo PLC, Allegheny Technologies, Kaiser Aluminum, and Gerdau SA. Cymat Technologies Ltd., a materials technology company, manufactures and sells stabilized aluminum foam products worldw... More

Cymat Technologies Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cymat Technologies' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cymat Technologies upside and downside potential and time the market with a certain degree of confidence.

Cymat Technologies Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Cymat Technologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cymat Technologies' standard deviation. In reality, there are many statistical measures that can use Cymat Technologies historical prices to predict the future Cymat Technologies' volatility.
Hype
Prediction
LowEstimatedHigh
0.010.1410.79
Details
Intrinsic
Valuation
LowRealHigh
0.010.1110.76
Details
Naive
Forecast
LowNextHigh
00.1210.77
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.130.140.16
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cymat Technologies. Your research has to be compared to or analyzed against Cymat Technologies' peers to derive any actionable benefits. When done correctly, Cymat Technologies' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Cymat Technologies.

Cymat Technologies Backtested Returns

Cymat Technologies is out of control given 3 months investment horizon. Cymat Technologies secures Sharpe Ratio (or Efficiency) of 0.0977, which signifies that the company had a 0.0977 % return per unit of risk over the last 3 months. We have analyze and collected data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.04% are justified by taking the suggested risk. Use Cymat Technologies Mean Deviation of 4.83, downside deviation of 16.73, and Risk Adjusted Performance of 0.1004 to evaluate company specific risk that cannot be diversified away. Cymat Technologies holds a performance score of 7 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.81, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cymat Technologies will likely underperform. Use Cymat Technologies total risk alpha, expected short fall, period momentum indicator, as well as the relationship between the value at risk and rate of daily change , to analyze future returns on Cymat Technologies.

Auto-correlation

    
  -0.7  

Very good reverse predictability

Cymat Technologies has very good reverse predictability. Overlapping area represents the amount of predictability between Cymat Technologies time series from 20th of April 2025 to 4th of June 2025 and 4th of June 2025 to 19th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cymat Technologies price movement. The serial correlation of -0.7 indicates that around 70.0% of current Cymat Technologies price fluctuation can be explain by its past prices.
Correlation Coefficient-0.7
Spearman Rank Test-0.62
Residual Average0.0
Price Variance0.0

Cymat Technologies lagged returns against current returns

Autocorrelation, which is Cymat Technologies otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cymat Technologies' otc stock expected returns. We can calculate the autocorrelation of Cymat Technologies returns to help us make a trade decision. For example, suppose you find that Cymat Technologies has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Cymat Technologies regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cymat Technologies otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cymat Technologies otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cymat Technologies otc stock over time.
   Current vs Lagged Prices   
       Timeline  

Cymat Technologies Lagged Returns

When evaluating Cymat Technologies' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cymat Technologies otc stock have on its future price. Cymat Technologies autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cymat Technologies autocorrelation shows the relationship between Cymat Technologies otc stock current value and its past values and can show if there is a momentum factor associated with investing in Cymat Technologies.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Cymat OTC Stock

Cymat Technologies financial ratios help investors to determine whether Cymat OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cymat with respect to the benefits of owning Cymat Technologies security.